Melissa Shelby
Psychiatry · Memphis, TNNPI 1861086654
Payments from drug & device makers
Across 731 payments — averaging $18.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
- Alkermes, Inc.$1K
- Otsuka America Pharmaceutical, Inc.$1K
- Johnson & Johnson$1K
- Supernus Pharmaceuticals, Inc.$1K
- plus $5K from 18 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 158 | $2,697 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 76 | $1,547 |
| Alkermes, Inc. | 62 | $1,375 |
| Otsuka America Pharmaceutical, Inc. | 84 | $1,207 |
| Johnson & Johnson | 53 | $1,031 |
| Supernus Pharmaceuticals, Inc. | 34 | $1,015 |
| Neurocrine Biosciences, Inc. | 31 | $753 |
| Lundbeck LLC | 39 | $705 |
| Vanda Pharmaceuticals Inc. | 35 | $592 |
| Axsome Therapeutics, Inc. | 29 | $580 |
| Takeda Pharmaceuticals U.S.A., Inc. | 32 | $510 |
| Tris Pharma Inc | 19 | $339 |
| Ironshore Pharmaceuticals Inc. | 17 | $266 |
| Bausch Health US, LLC | 10 | $209 |
| Merck | 11 | $181 |
| Acadia Pharmaceuticals Inc | 7 | $123 |
| Teva Pharmaceuticals USA, Inc. | 6 | $111 |
| Indivior Inc. | 6 | $110 |
| Collegium Pharmaceutical, Inc. | 6 | $96 |
| Sunovion Pharmaceuticals Inc. | 4 | $77 |
| Corium, LLC | 7 | $75 |
| E.r. Squibb & Sons, L.L.C. | 3 | $71 |
| Idorsia Pharmaceuticals US Inc | 1 | $13 |
| Noven Therapeutics, LLC | 1 | $13 |
How this compares
$13,694 in reported general payments places this provider in the 90th percentile of 503 psychiatry providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other psychiatry in Memphis
- Anita VarmaMemphis$1.3M
- Daniel BoydMemphis$69K
- Kenny TerryMemphis$14K
- Robert HoehnMemphis$12K
- Rakesh AminNashville$3M
- Brian BonfardinJohnson City$2.6M
- Paul NewhouseNashville$1.4M
- John FenleyJohnson City$1.4M
- Patricia AndrewsNashville$748K
- David SnowMaryville$605K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.